Monday November 23, 2009 2:37 PM ET
SmartMoney
Published December 19, 2006  |  A A A
Common Sense by James B. Stewart (Author Archive)

Beyond the Bonus Headlines, Goldman Sachs Has Been Solid

THIS IS THE SEASON for good cheer, holiday parties, charitable giving — and envy of your investment banker friends who just got their holiday bonuses.

True, this is a holiday phenomenon more prevalent in Manhattan, or London, Tokyo, Hong Kong or Shanghai, the world financial capitals where investment bankers and their entourages traditionally congregate. But it's spilling over to ski slopes at Vail, beaches on St. Barts, certain hotels in Miami Beach and Las Vegas, a bevy of fancy restaurants and bars — just about anywhere that suddenly seems too expensive for all the rest of us.

I read in The Wall Street Journal that the top five investment banks in New York alone will be bestowing a staggering $36 billion in bonuses on their employees this holiday season, according to executive search firm Options Group. That's up from $21.5 billion just a year ago. After a year of surging equity markets, record mergers and acquisitions, and mercifully few financial catastrophes, Wall Street is awash in money. No wonder several friends of mine seemed so smug at a holiday party this weekend when they mentioned, ever so subtly, that they'd been told their annual bonuses the previous week.

My own feeling is, if you can't beat them, join them. And by that I do not mean rush out and enroll in the nearest MBA program. It's much simpler to buy stock in a publicly traded investment bank, like the gold standard of the genre, Goldman Sachs (GS).

I have owned Goldman shares since shortly after it went public in 1999. I have never sold any, and it remains one of my core holdings. My only reservation at the time was that investment banks would prove to be like many Hollywood companies, where the talent walks off with all the profits. But I have known a number of investment bankers at Goldman over the years, and I have been consistently impressed by their work ethic, their competitive drive, their intelligence and breadth of knowledge, and most important, their integrity. Goldman has had the rare scandal, but overall, its culture seems to have done a remarkable job of instilling its core values in its employees.

My faith in Goldman has been rewarded over the years — only to a small fraction of the typical Goldman bonus, perhaps, but significant nonetheless. Last week, Goldman shares hit a new high of $206 before retreating slightly, and last Tuesday the firm reported record fourth-quarter and full-year profits of $3.15 billion and $9.54 billion on revenues of $9.41 billion and $37.67 billion. It's one thing for an Exxon Mobil (XOM), with its vast oil reserves, to report record earnings when oil prices are at $70 a barrel. But consider that Goldman has no tangible assets to speak of beyond its human capital. That makes it a little more understandable that Goldman is paying out a record $16.46 billion in employee compensation this year, an average $750,000 for each of its roughly 22,000 employees, from the loftiest managing director to the mailroom clerks. While much higher than last year, that's 40% of total revenue, a record low, and down from 43% last year. As a shareholder, I applaud that.

Goldman's sterling performance has pretty much laid to rest lingering doubts about its new chief executive, Lloyd Blankfein. When Blankfein replaced Henry Paulson earlier this year, some Goldman purists sniffed that he was a trader who lacked the polish of investment bankers, and that he'd gotten into the firm laterally, when Goldman acquired a trading firm where Blankfein worked. But I haven't heard a word since Goldman reported trading revenues of $25.56 billion, not only a record, but the largest portion of the firm's revenues. For better or worse, Goldman is a major trading firm. Owning shares is like having a piece of a hedge fund, without paying the exorbitant fees.

I have only two reservations for investors who are now pondering whether they should buy Goldman shares. The first is timing. Goldman shares rise and fall with the fortunes of Wall Street, and historically there have been much better opportunities. Given the importance of trading profits, and their inherent volatility — even for traders of Goldman's stature — there will likely be further pullbacks which would offer more attractive entry points. Goldman shares were as low as $139 this past summer. The second is less tangible. I've recently spoken with two business people involved in Goldman deals this year. Both said that Goldman bankers young enough to have been their children were insufferably arrogant. I hope their Goldman elders will remind them that pride goeth before a fall.

More broadly, I do sometimes ponder the disproportionate financial incentives we bestow on certain endeavors in the financial world, while many talented, highly educated college professors, classical musicians, and architects, to name just three underpaid professions, eke out a living. I can't claim any remarkable insights.

In the meantime, I neither envy my investment banker friends at Goldman nor aspire to join their ranks. I continue to enjoy their company. After all, since I'm a Goldman shareholder, they're at least in part working for me.

Count me among those surprised by Express Scripts's (ESRX) hostile bid on Monday for pharmacy-benefits manager Caremark Rx (CMX), the subject of this column on Nov. 7. The CVS (CVS) agreement to buy Caremark was a deal investors hated, with both CVS and Caremark shares plunging on the news. CVS didn't even offer a premium to Caremark's already-reduced trading price. This isn't a recipe for a bidding war.

Yet now we've gotten one. This is great for my Caremark shares, and I feel vindicated in my view that investors were undervaluing the benefits of the CVS deal. Still, this throws a wrench in the strategy that led me to buy CVS options, which had been gaining so nicely. For now I'm holding onto them. Should CVS lose out to the new bidder, its shares should still fare well (all those investors who hated the deal presumably prefer a stand-alone CVS.) If it succeeds, investors may give it new respect now that someone else has valued Caremark shares so richly. The danger, of course, is that CVS will raise its offer and overpay.


Follow SmartMoney on Facebook, Twitter & More: Facebook Twitter
Bookmark and Share RSS ETrade
Order ReprintsOrder Reprints
User Comments
Posted by: raud47
I own GS as well and it was the best performer in my portfolio this year. Does that mean I want to see those kind of bonuses? Of course not. Geoffgw and several other bloggers are on track with the absurd way these people make money off the rest of us.
Posted by: DKP50
Big 10-4 on the GS..Jim!
1. Bougth thema s well when went Public
2. Have been buying them ever since
3. Last Purchase> At $144...in summer
4. And It's Options as well...
and will be driving my CPA Nuts with envy.( Again this yr ) ..LOL
Merry Xmass everyone..
Posted by: geoffgw
To pay 40% of revenue as bonuses to Goldman employees is greed beyond imagination! When they do M&A deals, the idea is to rip-off the employees and shareholders out of as much money as possible, the rest is maximizing trading on the tiny margins but multiplied by big volumes, while the rest of us in the real world, produce the real value and profit and cash that these 'masters of the universe' manipulate into their pockets. I think there is a special place in hell for this kind of greed.
Posted by: wshang
Response to PAChristman -Posted: 3:08 PM On December 19, 2006

I don't own Goldman Sachs, but shareholders like Stewart are plenty happy. The share price is a reflection of how much shareholders value the 'brain equity' much akin to Google's employees.
Posted by: inflationrising
Talk about integrity and Goldman Sachs. Arent these the same guys who on several occassions, when asked to act as advisor in defense of a company being bought out, were instead quietly looking into buying themselves. And some of whose traders were busted for insider tips. Ofcourse they were fired. But dont tell me that happens unless the culture in the company actually condones it.
Advertisements

Related Quotes

GS 171.64 Up 1.63 0.96%
CVS 31.99 Up 0.35 1.11%
ESRX 87.52 Up 2.43 2.86%
 

Stock Compare

See how the stocks on this page stack up.